Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Barbara Mintzes, Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney

How drug companies are playing hardball with Australia’s PBS

Pixabay/Pexels

Australia is coming under increasing pressure from international drug companies demanding higher prices for their drugs.

In some cases, negotiations have broken down and companies have said they’ll withdraw their drugs from the market. In other cases, companies have said they’ll not apply for their drug to be listed on the Pharmaceutical Benefits Scheme (PBS) at all.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.